Parallel Advisors, LLC Agenus Inc Transaction History

Parallel Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 May 20, 2024	SELL	$1.31 - $2.04 $186 - $289	-142 Reduced 12.49%	995 $1,000
Q2 2023 Aug 04, 2023	SELL	$1.31 - $2.04 $186 - $289	-142 Reduced 12.49%	995 $1,000
Q1 2023 May 20, 2024	BUY	$1.45 - $2.95 $1,648 - $3,354	1,137 New	1,137 $1,000
Q1 2023 Apr 25, 2023	BUY	$1.45 - $2.95 $1,648 - $3,354	1,137 New	1,137 $1,000
Q2 2022 Aug 01, 2022	SELL	$1.3 - $2.64 $539 - $1,095	-415 Closed	0 $0
Q3 2018 Nov 01, 2018	BUY	$1.59 - $2.42 $659 - $1,004	415 New	415 $1,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Parallel Advisors, LLC with notifications on news.